CDRE Earnings

Cadre Holdings Reports Second Quarter 2025 Financial Results

Published August 05, 2025 at 08:15 PM

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Cadre Holdings, Inc. (NYSE: CDRE) (“Cadre” or “Company”), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025. Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025. Gross prof

Related Questions

How does the reported Q2 revenue compare to analysts’ consensus estimates? What is the company's capital‑expenditure plan for the next 12‑24 months? What is the current dividend policy and any changes announced? What is the outlook for new orders or contract wins in the law‑enforcement, first‑responder, military, and nuclear markets? What were the key drivers behind the change in net sales (e.g., new contracts, pricing changes, product mix, geographic performance)? What guidance did Cadre provide for the full‑year 2025 revenue, profit, and cash flow? What were the gross margin and operating margin percentages for the quarter and the six‑month period? How does the current cash position and debt level compare to the prior quarter and to the industry average? What were the year‑over‑year growth rates for net sales and gross profit? Are there any upcoming product launches or market expansions that could impact future revenue? How does Cadre’s performance stack up against its main competitors in the safety‑equipment sector? How does the sentiment (30) compare to the company's historical sentiment metrics? What is the expected impact on the CDRE stock price in the short and medium term? What was the net income and earnings per share for the quarter and how does it compare to prior periods? Are there any significant one‑time items or accounting adjustments affecting the results? Did management comment on any supply‑chain or regulatory risks that could affect future performance? Did the company announce any share buyback or stock issuance plans? Did the company provide earnings per share (EPS) and how does it compare to prior periods and forecasts?